Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture
Brilacidin, 세포 배양에서 SARS-CoV-2 억제 입증
Article
[키워드] acute respiratory syndrome coronavirus
AMPs
antimicrobial peptide
antimicrobial peptides
Antiviral
antiviral activity
biological properties
biological property
brilacidin
Calu
Calu-3
captures
causative agent
Cell culture
cell line
Clinical use
coronavirus
coronavirus 2
coronavirus disease
Coronavirus disease-19
COVID-19
COVID-19 disease
Critical
de novo
death
defensin
demonstrated
entry inhibition
Evidence
host defense
human lung
Increasing
inhibit SARS-CoV-2
inhibition
manuscript
morbidity and mortality
peptides
peptidomimetic
reduce
referred to
Remdesivir
respiratory
SARS-CoV-2
Severe acute respiratory syndrome
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
small molecule
strain
synergistic
therapeutic intervention
therapeutic options
These data
treat
Vero
Viral
viral entry
virus
[DOI] 10.3390/v13020271 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/v13020271 PMC 바로가기 [Article Type] Article